86.22.Z - Specialist medical practice
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
68 - Real estate activities
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72 - Scientific research and development activities
74 - Other professional, scientific and technical activities
84.12.Z - Management of public services in health, education, culture, and other social services
85.60 - Educational support activities
86.9 - Other healthcare activities
2023 | 2024 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 2,2 | 1,2 | -43,4 |
EBITDA | 2,4 | 1,6 | -35 |
Short time liabilities | 0,6 | 0,9 | 48,9 |
Equity capital | 6,2 | 7,2 | 15,2 |
Operating profit (EBIT) | 2,2 | 1,2 | -46,1 |
Assets | 6,8 | 8,1 | 18,8 |
Net profit (loss) | 1,9 | 1,2 | -38,1 |
Cash | 1,3 | 0,6 | -52,2 |
Liabilities and provisions for liabilities | 0,6 | 0,9 | 56,1 |
Net income from sale | 9,1 | 12,7 | 39,4 |
Working assets | 2,3 | 2,8 | 22,2 |
Depreciation | 0,2 | 0,4 | 75,5 |
% | % | p.p. | |
Profitability of capital | 30,8 | 16,5 | -14,3 |
Equity capital to total assets | 91,3 | 88,6 | -2,7 |
Gross profit margin | 24,1 | 9,8 | -14,3 |
EBITDA Margin | 26,5 | 12,4 | -14,1 |
Days | Days | Days | |
Short term commitment turnover cycle | 24 | 25 | 1 |
Current financial liquidity indicator | 3.868273973464966 | 3.029061794281006 | -0,9 |
Net dept to EBITDA | -0.5361841320991516 | -0.39394956827163696 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane